Advertisement

Danish cyclist Høj admits to doping

AFP/The Local
AFP/The Local - [email protected]
Danish cyclist Høj admits to doping
Frank Høj. Photo: Nils Meilvang/Scanpix

Frank Høj has admitted to using EPO but denied charges that he smuggled drugs into the Danish team's Olympic Village quarters in Athens.

Advertisement

Danish former professional road cyclist Frank Høj on Sunday admitted to doping at the beginning of his career, but claimed he stopped in 1998 after the Festina drug scandal.
 
"As a neo-professional, I unfortunately have to ... admit that I tried to ride using EPO," he told Danish broadcaster TV2, referring to a banned blood-booster.
 
"I have tried to take it. I probably haven't taken it in the amounts that would have produced results," he added.
 
The 42-year-old said he stopped doping himself in 1998, when the Festina drug scandal on the Tour de France almost brought the race to its knees.
 
He denied claims by Michael Rasmussen that he had smuggled the doping substance Synacthen to the Danish team inside the Olympic Village -- and used it himself -- in Athens in 2004.
 
"You can go in and look at my results in the period until the Festina scandal. They are not impressive. After the Festina scandal I never wanted to touch any" banned substances, he said.
 
Rasmussen quit the 2007 Tour de France when he was wearing the race leader's yellow jersey and admitted in 2013 that he had used banned drugs between 1998 and 2010.
 
Høj won the Danish national championship in 1998 and finished in the top ten in the road race at the 2004 and 2008 Olympic Games.
 
He became a professional in 1995 and rode in the Tour de France, the Giro d'Italia and the Vuelta a Espana before retiring in 2010.

More

Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also